cmv
common
infecti
caus
mental
disabl
newborn
develop
countri
detect
cmv
antibodi
effect
systemat
screen
cmv
infect
instanc
cmv
immunoglobulin
g
igg
avid
assay
help
distinguish
primari
nonprimari
human
cmv
infect
key
immun
method
use
cmv
antibodi
detect
enzymelink
immunosorb
assay
elisa
elecsi
electrochemiluminesc
immunoassay
eclia
immunofluoresc
assay
ifa
flow
cytometri
fcm
immunoblot
addit
new
immun
method
cmv
antibodi
detect
develop
chemilumines
microparticl
immunoassay
cmia
protein
microarray
howev
method
suffer
inher
limit
length
test
time
need
expens
equip
specialist
skill
low
sensit
complic
sampl
prepar
process
exampl
convent
elisa
still
main
diagnost
test
cmv
commerci
cmv
elisa
kit
avail
although
elisa
often
use
comparison
method
cmv
antibodi
detect
obviou
shortcom
includ
need
tracer
label
plate
wash
indirect
format
detect
length
time
necessari
test
thu
rapid
simpl
direct
highthroughput
method
cmv
antibodi
detect
urgent
need
first
biosensor
base
imag
ellipsometri
bie
develop
compar
method
advantag
bie
evid
eg
highthroughput
multiplex
analysi
quantit
labelfre
rapid
test
previou
applic
bie
mainli
focu
biomed
field
highthroughput
diseas
diagnosi
hepat
b
viru
hbv
marker
detect
avian
influenza
viru
aiv
antibodi
sever
acut
respiratori
syndrom
sar
detect
thu
biosensor
technolog
offer
import
tool
diseas
diagnosi
new
applic
recent
develop
includ
analysi
interact
tropomyosin
allergen
antibodi
interact
solubl
nethylmaleimidesensit
factor
attach
receptor
snare
protein
date
howev
bie
appli
detect
cmv
antibodi
particularli
identif
cmv
igg
igm
antibodi
purpos
studi
detect
antibodi
patient
serum
use
bie
microarray
well
specif
identifi
captur
igg
antibodi
cmv
antibodi
cmv
qualit
detect
use
bie
goat
antibodi
human
igg
antiigg
ad
area
captur
cmv
antibodi
confirm
igg
antibodi
cmv
standard
curv
repres
differ
concentr
gradient
also
establish
quantit
detect
cmv
antibodi
concentr
cmv
antibodi
serum
quantit
detect
bie
compar
use
elisa
silicon
wafer
purchas
gener
research
institut
nonferr
metal
china
nhydroxysuccinimid
nh
hydrochlorid
edc
bovin
serum
albumin
bsa
igg
block
buffer
purchas
sigma
antiigg
goat
antibodi
human
igm
antiigm
purchas
beij
bo
sheng
biotechnolog
co
ltd
purchas
galaxybio
fusion
three
segment
strong
antigen
epitop
fusion
multiepitop
enhanc
sensitivityspecif
reduc
fals
neg
thu
use
ligand
bie
assay
purifi
cmv
antibodi
cterm
rabbit
mgml
purchas
antibodiesonlinecom
patient
serum
sampl
purchas
qilu
hospit
shandong
univers
clinic
inform
list
tabl
file
torch
elisa
kit
use
analyz
serum
sampl
purchas
medson
inc
detect
process
analysi
execut
accord
manufactur
instruct
micropl
coat
nativ
cmv
antigen
highli
purifi
sucros
gradient
centrifug
inactiv
solid
phase
first
treat
dilut
sampl
igg
molecul
cmv
captur
present
antigen
wash
sampl
compon
bound
anticmv
igg
molecul
detect
addit
specif
polyclon
antihigg
antibodi
label
peroxidas
hrp
second
incub
enzym
captur
solid
phase
act
substratechromogen
mixtur
gener
optic
signal
proport
amount
anticmv
igg
antibodi
present
sampl
calibr
curv
calibr
first
intern
standard
make
possibl
quantit
determin
igg
antibodi
patient
ne
solut
prepar
nh
edc
deioniz
water
milliq
plu
system
millipor
bedford
phosphatebuff
salin
pb
prepar
mm
nacl
mm
kcl
mm
mm
ph
deioniz
water
pbst
buffer
prepar
pb
mgml
prepar
pbst
bsa
mgml
prepar
pbst
block
reagent
vol
vol
mixtur
mgml
bsa
block
buffer
purifi
cmv
antibodi
igg
antiigg
antiigm
dilut
concentr
mgml
pbst
serum
sampl
dilut
indic
pbst
qualit
quantit
detect
bie
combin
high
spatial
resolut
imag
ellipsometri
figa
file
microfluid
system
figb
file
analyz
biomolecular
interact
microfluid
system
use
surfac
pattern
array
product
well
solut
deliveri
ligand
immobil
target
captur
microfluid
system
four
main
part
sampl
plate
multicel
array
microchannel
pump
multicel
array
form
polydimethylsiloxan
pdm
pattern
mold
contact
surfac
silicon
substrat
cell
inlet
outlet
solut
passag
physic
size
cell
inlet
microchannel
place
sampl
plate
outlet
microchannel
connect
pump
ismatec
switzerland
wwwismateccom
offer
neg
pressur
simpl
channel
junction
use
serial
parallel
format
simultan
analyz
singl
multipl
sampl
imag
ellipsometri
display
techniqu
ultrathin
film
surfac
character
use
read
analyz
protein
array
made
microfluid
system
incid
wave
polar
light
irradi
sampl
probe
beam
therebi
modifi
result
reflect
transmiss
beam
abil
carri
sampl
inform
protein
layer
thick
imag
ellipsometri
use
detect
layer
thick
reflect
intens
repres
grayscal
variat
layer
thick
lead
chang
grayscal
valu
refract
index
invari
grayscal
valu
directli
proport
thick
protein
layer
within
rang
nm
layer
thick
ie
kd
light
intens
layer
thick
condit
k
constant
determin
protein
layer
known
grayscal
valu
known
thick
also
relationship
surfac
concentr
film
thick
surfac
concentr
k
thu
grayscal
valu
directli
reflect
layer
thick
surfac
concentr
higher
grayscal
valu
thicker
layer
higher
surfac
concentr
silicon
wafer
cut
rectangl
rins
deioniz
water
soak
piranha
solut
volvol
min
increas
number
silanol
group
wafer
surfac
rins
deioniz
water
ethanol
wafer
soak
mixtur
apt
absolut
ethanol
apt
absolut
ethanol
volvol
incub
h
gentl
agit
reaction
apt
surfac
silanol
group
result
coval
immobil
ofosi
oh
form
layer
dens
pack
amino
group
surfac
rins
three
time
absolut
ethanol
wafer
incub
satur
solut
succin
anhydrid
ethanol
h
gentl
agit
group
succin
anhydrid
react
osi
oh
group
immobil
surfac
gener
carboxyl
group
prepar
wafer
store
ethanol
abovemodifi
silicon
wafer
use
substrat
piec
silicon
wafer
place
microfluid
mold
microfluid
system
surfac
wafer
pattern
form
small
regular
cell
array
format
carboxyl
group
activ
pump
ne
cell
flow
rate
pass
surfac
wafer
presenc
nh
edc
transfer
carboxyl
group
sulfonh
ester
react
amino
group
protein
immobil
protein
surfac
next
ligand
immobil
ligand
probe
pump
cell
per
cell
third
block
occur
pump
block
reagent
cell
per
cell
pass
ligand
area
thu
sens
array
surfac
form
catch
cmv
antibodi
fourth
target
detect
pbst
use
blank
control
per
cell
purifi
cmv
antibodi
posit
control
per
cell
pump
sever
individu
cell
simultan
patient
serum
sampl
also
pump
remain
cell
per
cell
cmv
antibodi
serum
captur
interact
sens
surfac
cell
rins
pbst
per
cell
everi
two
consecut
oper
step
final
microarray
wafer
remov
microfluid
system
rins
deioniz
water
dri
nitrogen
wafer
analyz
use
imag
ellipsometri
cmv
antibodi
solut
serum
interact
surfac
form
complex
layer
area
becam
thicker
experiment
result
record
imag
grayscal
bind
cmv
antibodi
result
signific
increas
grayscal
valu
detect
specif
antibodi
cmv
ligand
immobil
two
column
fig
pbst
buffer
ad
blank
control
two
area
first
row
simultan
purifi
cmv
antibodi
mgml
ad
posit
control
two
area
second
row
normal
serum
without
cmv
antibodi
ad
neg
control
two
area
third
row
three
patient
serum
sampl
see
tabl
file
sampl
inform
analyz
follow
row
respect
increas
light
reflect
densiti
area
reveal
cmv
antibodi
sampl
interact
immobil
chip
analyz
type
cmv
antibodi
captur
fig
first
step
igg
immobil
ligand
first
second
column
simultan
immobil
third
fourth
fifth
sixth
column
second
step
sampl
ad
third
fourth
column
sampl
ad
fifth
sixth
column
pbst
buffer
ad
blank
control
remain
area
third
step
antiigg
antiigm
ad
third
fourth
row
identifi
confirm
antibodi
captur
ligand
igg
igm
pbst
buffer
ad
blank
control
remain
area
establish
calibr
curv
serum
sampl
iuml
see
tabl
file
use
five
level
serial
dilut
contain
iuml
cmv
antibodi
prepar
pbst
immobil
ligand
two
column
fig
block
pbst
buffer
cmv
antibodi
normal
serum
without
cmv
antibodi
ad
blank
posit
neg
control
respect
first
second
third
row
respect
sampl
ad
fourth
eighth
row
respect
concentr
plot
xaxi
variat
grayscal
valu
compar
blank
control
plot
yaxi
gener
calibr
curv
fig
acquir
calibr
curv
concentr
antibodi
sampl
unknown
concentr
could
determin
curv
accord
grayscal
valu
measur
everi
sampl
repeat
two
area
one
chip
fig
commerci
elisa
cmv
antibodi
kit
use
control
accord
manufactur
instruct
statist
analys
correspond
pvalu
calcul
singl
factor
analysi
varianc
microsoft
offic
excel
accord
quantiti
area
imag
patient
serum
sampl
tabl
file
qualit
quantit
detect
experi
signific
chang
grayscal
valu
detect
area
compar
blank
control
area
detect
area
deem
posit
signal
pvalu
p
detect
area
deem
neg
signal
comparison
elisa
bie
data
result
two
method
deem
agreement
p
p
two
method
deem
disagr
correl
coeffici
rvalu
bie
elisa
calcul
analysi
correl
coeffici
microsoft
offic
excel
tabl
b
file
compar
blank
control
area
purifi
cmv
antibodi
patient
serum
sampl
detect
area
markedli
thicker
film
averag
grayscal
valu
display
signific
increas
neg
control
area
fig
mean
grayscal
valu
blank
control
measur
valu
purifi
cmv
antibodi
measur
thu
mean
grayscal
valu
purifi
cmv
antibodi
minu
mean
grayscal
valu
blank
control
p
valu
neg
control
mean
grayscal
valu
neg
control
minu
mean
grayscal
valu
blank
control
p
indic
specif
interact
purifi
cmv
antibodi
therefor
cmv
antibodi
patient
sampl
could
captur
immobil
substrat
inde
averag
grayscal
valu
serum
sampl
analyz
significantli
increas
rel
control
fig
mean
serum
valu
mean
grayscal
valu
serum
minu
mean
grayscal
valu
blank
control
p
indic
cmv
antibodi
abund
serum
sampl
consist
elisa
result
tabl
file
purifi
human
igg
use
ligand
averag
grayscal
valu
antiigg
detect
area
significantli
increas
antiigm
detect
area
left
two
column
fig
mean
grayscal
valu
antiigg
minu
mean
grayscal
valu
blank
control
p
mean
valu
antiigm
minu
mean
grayscal
valu
blank
control
p
data
indic
specif
interact
antiigg
human
igg
immobil
chip
could
use
refer
determin
whether
antibodi
sampl
igg
compar
cmv
antibodi
area
antiigg
detect
area
display
signific
increas
antiigm
detect
area
fig
exampl
valu
sampl
valu
antiigg
differ
p
howev
valu
antiigm
differ
obviou
p
indic
igg
cmv
antibodi
captur
chip
sampl
detect
valu
antiigg
increas
p
result
also
indic
content
igg
sampl
differ
five
concentr
gradient
serum
sampl
iuml
see
tabl
file
measur
serial
dilut
sampl
use
determin
sensit
bie
assay
fig
found
chang
signal
intens
consist
increas
cmv
antibodi
concentr
cmv
antibodi
detect
sensit
level
reach
iuml
grayscal
valu
blank
control
grayscal
valu
dilut
low
iuml
ie
greater
control
p
repeat
test
time
result
demonstr
sensit
assay
reach
iuml
less
variat
grayscal
valu
link
correspond
concentr
cmv
antibodi
rang
iuml
calibr
curv
shown
fig
concentr
unknown
sampl
could
determin
accord
correspond
grayscal
valu
calibr
curv
cmv
patient
tabl
file
quantit
result
elisa
test
bie
fig
differ
serum
sampl
chang
bie
signal
intens
differ
comparison
result
two
method
shown
fig
singl
factor
analysi
correl
coeffici
analysi
reveal
result
agreement
elisa
bie
f
p
r
tabl
b
file
highthroughput
detect
suitabl
mass
cmv
screen
women
childbear
age
coupl
microfluid
technolog
bie
greatli
improv
throughput
cmv
detect
one
chip
microarray
develop
multipl
cell
immobil
differ
ligand
differ
cmv
antibodi
subtyp
imag
ellipsometri
also
suitabl
highthroughput
analysi
use
visual
variat
signal
unit
microarray
high
spatial
resolut
patient
sampl
analysi
result
one
microarray
simultan
identifi
data
obtain
sever
second
use
imag
ellipsomet
present
method
provid
simultan
reaction
area
enhanc
throughput
lower
cost
bie
may
use
clinic
mass
cmv
screen
healthi
birth
futur
antibodi
detect
wide
avail
clinic
diagnosi
cmv
infect
howev
identif
antibodi
type
may
help
determin
cours
diseas
bie
may
use
clinic
primari
screen
tool
cmv
patient
igm
produc
larg
amount
earli
infect
reach
peak
first
month
follow
igg
product
level
igm
declin
month
follow
onset
infect
wherea
igg
level
persist
rest
patient
life
determin
igg
avid
provid
addit
guidanc
infect
statu
low
avid
igg
initi
present
increas
time
posit
result
igm
combin
lowtomoder
igg
suggest
avid
primari
cmv
infect
within
past
month
visual
bie
imag
fig
could
reflect
type
via
differ
bright
technolog
achiev
rapid
screen
date
work
simpli
demonstr
igg
type
antibodi
detect
bie
igm
antibodi
need
screen
specif
antigen
incorpor
futur
practic
applic
present
method
mention
rel
sensit
detect
cmv
antibodi
littl
provid
absolut
sensit
compar
method
absolut
sensit
bie
reach
iuml
good
resolut
rang
iuml
calibr
curv
quantit
detect
refer
rang
detect
cmv
antibodi
previous
publish
exampl
elecsi
roch
diagnost
immunoassay
equivoc
rang
iuml
cmv
igg
experi
elisa
control
method
refer
rang
iuml
therefor
sensit
bie
biosensor
refer
rang
alreadi
reach
clinic
standard
howev
substanti
discord
elisa
bie
patient
ie
sampl
patient
display
stronger
signal
use
elisa
bie
elisa
anticmv
igg
molecul
detect
addit
polyclon
specif
antihigg
antibodi
label
horseradish
peroxidas
hrp
contrast
bie
biosensor
directli
identifi
variat
surfac
anticmv
igg
concentr
captur
target
without
secondari
label
thu
labelfre
method
may
avoid
interfer
factor
addit
grayscal
imag
offer
uniform
area
help
avoid
fals
posit
signal
correl
coeffici
rvalu
pvalu
calcul
exclud
number
sever
mutat
rvalu
p
statist
result
show
agreement
elisa
bie
conclus
develop
labelfre
multiplex
screen
cmv
igg
biosensor
method
highthroughput
detect
suitabl
mass
cmv
screen
women
childbear
age
result
demonstr
sensit
bie
alreadi
reach
clinic
diagnos
standard
anticmv
igg
thu
basi
anticmv
igg
detect
bie
use
qualit
quantit
detect
type
cmv
antibodi
use
simpl
fast
procedur
